Novoprotein Scientific Inc. (SHA:688137)
China
· Delayed Price · Currency is CNY 32.27
+0.06 (0.19%)
At close: Apr 18, 2025, 2:57 PM CST
Novoprotein Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | - | 12.84 | 90.72 | 149.01 | 83.05 | Upgrade
|
| Depreciation & Amortization | - | 22.5 | 20.46 | 9.2 | 1.67 | Upgrade
|
| Other Amortization | - | 1.63 | 1.38 | 0.78 | 0.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0 | -0.04 | -0.03 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.09 | 0.08 | 0.15 | -0.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -17.19 | -4.16 | -0.85 | -0.11 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -1.58 | 1.22 | 3.9 | 1.03 | Upgrade
|
| Other Operating Activities | - | 36.9 | 19.63 | 15.17 | 8.56 | Upgrade
|
| Change in Accounts Receivable | - | 62.8 | -57.73 | -52.73 | -24.72 | Upgrade
|
| Change in Inventory | - | -41.26 | -51.84 | -30.96 | -12.43 | Upgrade
|
| Change in Accounts Payable | - | -8.62 | -15.18 | -29.11 | 41.73 | Upgrade
|
| Change in Other Net Operating Assets | - | 10.48 | 7.01 | 7 | 4.58 | Upgrade
|
| Operating Cash Flow | - | 69.16 | 3.38 | 70.97 | 97.56 | Upgrade
|
| Operating Cash Flow Growth | - | 1948.16% | -95.24% | -27.26% | - | Upgrade
|
| Capital Expenditures | - | -44.94 | -36.77 | -69.95 | -11.8 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Investment in Securities | - | -56.6 | -963.3 | 25 | -25 | Upgrade
|
| Other Investing Activities | - | 20.11 | 0.6 | 1 | 0.11 | Upgrade
|
| Investing Cash Flow | - | -81.42 | -999.45 | -43.95 | -36.69 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 13 | Upgrade
|
| Total Debt Issued | - | - | - | - | 13 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -17 | Upgrade
|
| Long-Term Debt Repaid | - | -17.32 | -11.34 | -4.85 | - | Upgrade
|
| Total Debt Repaid | - | -17.32 | -11.34 | -4.85 | -17 | Upgrade
|
| Net Debt Issued (Repaid) | - | -17.32 | -11.34 | -4.85 | -4 | Upgrade
|
| Issuance of Common Stock | - | - | 1,742 | 117.67 | 20 | Upgrade
|
| Common Dividends Paid | - | -35.09 | - | -16.29 | -1.03 | Upgrade
|
| Other Financing Activities | - | -1.52 | 2.51 | -2 | -9.61 | Upgrade
|
| Financing Cash Flow | - | -53.93 | 1,733 | 94.53 | 5.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.54 | 2.64 | -0.79 | -1.89 | Upgrade
|
| Net Cash Flow | - | -65.65 | 739.94 | 120.75 | 64.35 | Upgrade
|
| Free Cash Flow | - | 24.22 | -33.39 | 1.02 | 85.76 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -98.82% | - | Upgrade
|
| Free Cash Flow Margin | - | 15.81% | -12.62% | 0.30% | 47.69% | Upgrade
|
| Free Cash Flow Per Share | - | 0.34 | -0.58 | 0.03 | 5.40 | Upgrade
|
| Cash Income Tax Paid | - | 2.63 | 58.63 | 71.24 | 21.79 | Upgrade
|
| Levered Free Cash Flow | - | -403.58 | -68.42 | -40.11 | 52.18 | Upgrade
|
| Unlevered Free Cash Flow | - | -401.34 | -65.89 | -38.99 | 52.8 | Upgrade
|
| Change in Net Working Capital | - | 360.25 | 108.56 | 95.43 | 2.31 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.